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and colposcopically, biopsies were available for 279 con-
ventional preparations (17.6%) and 325 LBC preparations 
(22.2%). No significant differences were found between the 
methods with respect to diagnostic performance.  Conclu-
sion: LBC was significantly superior to conventional smears 
for the detection of LSILs and HSILs, but these results did not 
influence biopsy confirmation. Both methods showed simi-
lar performances with high positive predictive values but 
very low sensitivities.  © 2013 S. Karger AG, Basel 
 Introduction 
 The impassioned disputes between defenders of con-
ventional Pap smears and those who believe in the su-
premacy of liquid-based cytology (LBC) are generally 
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 Abstract 
 Objective: This study sought to ascertain the significance of 
augmented high-grade squamous intraepithelial lesion 
(HSIL) detection by Pap test using both conventional smear 
and liquid-based cytology (LBC) in a high-risk population. 
 Study Design: We conducted a direct-to-vial study to com-
pare the diagnostic performance of Pap smear versus LBC in 
a high-risk population of women referred for colposcopy at 
a gynecologic ambulatory clinic at the Barretos Cancer Hos-
pital in Brazil during 2011.  Results: The detection of both 
low-grade squamous intraepithelial lesions (LSILs) and HSILs 
was significantly greater (p = 0.04 and p = 0.033, respective-
ly) in the LBC arm [84 LSIL cases (5.7%) and 148 HSIL cases 
(10.1%)] than in the conventional smear arm [66 LSIL cases 
(4.1%) and 126 HSIL cases (7.9%)]; however, no differences 
were found for invasive squamous carcinoma or adenocarci-
noma (p = 0.678). Of 3,071 women who were examined cy-
tologically (1,604 conventional preparations and 1,467 LBC) 
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supported by the belief that one of these methods has the 
potential to detect more cases of high-grade squamous 
intraepithelial lesions (HSILs) on routine screenings for 
cervical cancer even in high-risk settings  [1] . Moreover, 
LBC is believed to improve the quality of sample prepa-
rations, be more cost-effective, allow the use of comput-
er-assisted screening and provide residual material for 
ancillary testing, including human papillomavirus 
(HPV) testing, all of which strongly favor the use of LBC 
 [2–4] .
 To date, the routine method of cervical cancer screen-
ing supported by the Federal Government in Brazil is 
based on the conventional Papanicolaou (Pap) test. Un-
fortunately, despite many efforts, the high incidence and 
high mortality rate of cervical cancer have not been ade-
quately addressed, especially in poor regions  [5] . The 
conventional Pap test is a sophisticated methodology that 
requires a high degree of refinement when collecting, pre-
paring and fixing the cervical samples  [6] . The reputation 
for simplicity of the conventional Pap test has been shown 
to be undeserved; technicians should be regularly trained, 
the quality control must be rigorous, and the number of 
slides examined each day must be limited for the method 
to be minimally efficient. Consequently, the price of this 
complex test is not insignificant  [6, 7] . Therefore, new 
methodologies are currently being advocated to over-
come the limitations of conventional Pap tests, increase 
the detection of cervical lesions and reduce mortality  [7] . 
LBC appears to be an attractive option to replace the con-
ventional method because it preserves cervical samples 
immediately after collection in an LBC vial, which pro-
vides a better preparation and a presumed superior cyto-
logical evaluation  [3] . In addition, LBC is a realistic op-
tion for computer-assisted analysis, molecular testing 
and HPV detection  [5, 7] .
 The RODEO study was designed to evaluate 30,000 
consecutive women at the Barretos Cancer Hospital (Bar-
retos, Brazil), the Leonor Mendes de Barros Hospital and 
the Hospital das Clínicas of the Faculty of Medicine of the 
São Paulo State University (São Paulo, Brazil). The prin-
cipal goal of our results is to apply them in an algorithm 
to prevent and control cervical cancer. The RODEO study 
was implemented at the Barretos Cancer Hospital to pro-
vide a realistic basis for the integration of LBC, automat-
ed screening and the inclusion of HPV DNA testing in the 
screening routine. This study reports on the performance 
of LBC versus conventional preparations in a high-risk 
setting and discusses the significance of increased detec-
tion of cervical lesions using manual screening condi-
tions.
 Materials and Methods 
 Study Design 
 This study represents a part of the RODEO study that was per-
formed exclusively at the Barretos Cancer Hospital. The study was 
a direct-to-vial study, and the samples were collected in the Gyne-
cologic Oncology Ambulatory Clinic after women were referred 
due to abnormal Pap tests, for treatment to control cervical lesions 
and for other reasons.
 Only women whose Pap tests were carried out in the Gyneco-
logic Oncology Department were included. Pregnant women were 
not enrolled in the study because endocervical sampling is contra-
indicated for them. Samples were collected in 4 ambulatory clinics, 
and the women were randomly assigned to receive LBC or a con-
ventional smear. These women were referred to the ambulatory 
clinics for various reasons, including follow-up after treatment for 
cancer of the cervix, vulva, ovaries and endometrium, among oth-
ers. Because of their medical histories, these women were consid-
ered high risk for HPV-induced diseases.
 Preparation of Cytological Samples and Diagnostic Classification 
 Conventional Pap test samples were collected using an Ayre’s 
wooden spatula to scrape the ectocervix and a Combi Cervex TM 
brush (Rover, The Netherlands) to scrape the endocervix. Only a 
single slide was prepared for each sample. The samples were 
smeared on a slide and immediately fixed with a polyethylene gly-
col fixative spray. LBC samples were collected using a Combi Cer-
vex brush (Rover), placed into a plastic vial with SurePath TM liquid 
medium (Tripath Imaging Inc., Burlington, N.C., USA) and pre-
pared according to the manufacturer’s instructions. The classifica-
tion of the cytological alterations was performed according to the 
Bethesda 2001 system  [8] .
 Statistical Analysis 
 The statistical data were analyzed using SPSS for Windows ® 
version 20.0 (SPSS Inc., Chicago, Ill., USA). A t test was used to 
compare the women’s ages. The prevalence rates were compared 
using a z approximation. Confidence intervals for the proportions 
were also calculated. The significance level was set at 5%. Cervical 
biopsy [cervical intraepithelial neoplasia (CIN) 1+, CIN2+] was 
considered the gold standard for calculating the sensitivity, speci-
ficity and predictive values of the conventional and LBC methods. 
Analysis of the area under the curve (AUC) of a receiver operating 
characteristic curve was used to compare the diagnostic perfor-
mance of each cytology method in the different settings.
 Ethics 
 All women signed an informed consent document before being 
included in the study. The study protocol was approved by the
local Ethics Committee of the Barretos Cancer Hospital (No. 
244/2009).
 Results 
 A total of 4,726 women were included in the study; of 
these, 2,378 women (50.3%) underwent conventional 
smears and 2,348 women (49.7%) underwent LBC. The 
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mean age for the Pap smear group was 45.6 years, and the 
mean age for the LBC group was 48.6 years (t test: p < 
0.001). Abnormal Pap test results were detected in 390 con-
ventional smears (16.4%) and 514 LBCs (22.2%; p < 0.001).
 For diagnostic performance analyses comparing con-
ventional smears with LBC, patients with a history of pel-
vic radiotherapy were excluded from the study. There-
fore, 1,604 Pap smears and 1,467 LBCs were included in 
this portion of the study.
 Table 1 shows the distribution of the cytological results 
and the overall distribution following the cytological ex-
aminations. Abnormal cases were identified according to 
their cytological classification, and these specific cytological 
alterations showed significant differences between the LBC 
and conventional smears overall (p < 0.001). The main dif-
ferences between LBC and conventional smears, respec-
tively, included the following: low-grade squamous in-
traepithelial lesion (LSIL), 84 cases (5.7%) vs. 66 cases (4.1%; 
p = 0.040), and HSIL, 148 cases (10.1%) vs. 126 cases (7.9%; 
p = 0.033). There was no difference in the unsatisfactory 
result rates between LBC and conventional smears.
 Table 2 extends the data from  table 1 and correlates the 
cytological diagnoses with the biopsy results.  Table  3 
shows the performance in diagnosing CIN1+ and CIN2+ 
according to the type of cytology and the cytological cri-
terion (ASC-H+, LSIL+, HSIL+). Both of the methods 
performed similarly despite the significantly higher num-
ber of LSILs and HSILs detected by LBC. Using biopsy-
proven CIN1+ as a cutoff, no significant differences were 
observed between the methods. However, using CIN2+ 
as a cutoff showed a slightly favorable result for conven-
tional smears when calculated for the ASC-H+ or LSIL+ 
cytological criterion.
 Interestingly, for both methods, the sensitivity and 
negative predictive values were higher if ASC-H+ was ad-
opted as the cutoff, and the values diminished progres-
sively when LSIL+ and HSIL+ were used as the cutoffs. 
Conversely, the specificity and positive predictive values 
were lower for an ASC-H+ cutoff and rose progressively 
for LSIL+ and HSIL+ cutoffs.
 Higher AUCs were achieved when HSIL+ was used 
as the cytological criterion to diagnose HSILs. In this 
setting, there was no difference in the diagnostic perfor-
mance between LBC and conventional smears. The re-
spective AUCs were 0.686 and 0.712 (p = 0.482).
 Discussion 
 Methodological improvements in gynecological cytol-
ogy represent essential tools that should be incorporated 
into programs for cancer prevention because cytotech-
nologists need a more robust and adequate armamentar-
Table 1.  Distribution of cases according to the result and type of cervical cytology
Result of cervical cytology Conventional cytology
(n = 1,604)
LBC (n = 1,467) Prevalence
rate
p value
Negative 1,267 (79.0%) 1,090 (74.3%) 0.94 0.002
ASC-US 58 (3.6%) 50 (3.4%) 0.94 0.763
ASC-H 60 (3.7%) 68 (4.6%) 1.24 0.211
AGC 5 (0.3%) 5 (0.3%) 1.00 1.000
LSIL 66 (4.1%) 84 (5.7%) 1.39 0.040
HSIL 126 (7.9%) 148 (10.1%) 1.28 0.033
Invasive carcinoma (SCC/AD) 6 (0.4%) 7 (0.5%) 1.25 0.678
Unsatisfactory 16 (1.0%) 15 (1.0%) 1.02 0.949
 p values were calculated using z approximation. ASC-US = Atypical squamous cells of undetermined signifi-
cance; ASC-H = atypical squamous cells – cannot exclude HSIL; AGC = atypical glandular cells; SCC = squamous 
cell carcinoma; AD = adenocarcinoma.
Table 2.  Number and percentage of cases with cervical biopsy data 
according to the cervical cytology result
Type of cytology  Biopsy
 negative CIN1+ CIN2/3+
Conventional
LSIL+
HSIL+
13 (22.4%)
15 (12.0%)
20 (34.5%)
13 (10.4%)
25 (43.1%)
97 (77.6%)
LBC
LSIL+
HSIL+
19 (25.0%)
23 (15.6%)
27 (35.5%)
8 (5.4%)
30 (39.5%)
116 (78.9%)
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ium to detect cervical alterations (mainly HSILs) than is 
provided by the conventional cytological smear. The diag-
nostic performance calculations for both of the methods 
we tested followed very stringent parameters, which cer-
tainly repressed the positive impact of LBC performance, 
even though almost 100% more HSILs were detected by 
LBC compared to conventional smear preparations. The 
conventional Pap test, even when performed in a con-
trolled setting, has important limitations when identifying 
cervical lesions and has not infrequently demonstrated in-
ferior performance compared with LBC in reports from 
developed countries  [9] . However, when LBC and con-
ventional smears have been measured against a biopsy-
proven result, the differences have not shown significant 
improvements in terms of ameliorated performance in 
other reports from developed countries  [10] . However, 
this assumption is not necessarily true for poorer settings 
 [1] . The reasons for these discrepancies could be attrib-
uted to several factors, and most of those factors have been 
discussed previously. The level of experience of the cyto-
technicians and favorable conditions for screening are 
critical for Pap test performance  [11] . Moreover, conven-
tional smears largely depend on the expertise of well-
trained nurses and medical doctors to collect the samples, 
smear them onto slides and fix them properly. Profession-
als with high levels of expertise certainly represent an im-
portant variable for the success of cancer prevention pro-
grams, but even under the good conditions that we have 
at Barretos Cancer Hospital, we observed that convention-
al cytology identified significantly fewer cytological ab-
normalities than LBC. The real meaning of the higher de-
tection rate for LSILs and HSILs in our series is a challeng-
ing point that should be evaluated seriously. Firstly, the 
Pap test is recognized as an excellent method in terms of 
its specificity, which is usually very high  [11–14] . Accord-
ingly, if a Pap test result is categorized as an HSIL, the
result is likely to be correct. In addition, even without
colposcopic evidence of a cervical lesion, it is prudent to 
carefully follow women diagnosed with an HSIL. This
recommendation is most likely the most disputable issue 
regarding the real meaning of the superior LBC perfor-
mance. Well-conducted meta-analyses based on reports 
from developed countries have systematically demon-
strated that LBC and conventional cytological prepara-
tions perform similarly to detect HSILs  [9, 10] . However, 
a number of studies have described better performance by 
LBC in high-risk settings to detect high-grade lesions and 
to decrease the unsatisfactory preparation rate  [11–14] .
 The identification of cytological abnormalities appears 
to be favored in LBC samples because of the clean back-
ground and the homogenous and randomized distribu-
tion of normal and abnormal cells. Not surprisingly, the 
specificity of LBC has also been recognized to be higher 
than that of conventional smears  [11] . Moreover, the su-
perior performance of LBC to detect cervical lesions has 
been supported by previous studies in Brazil in popula-
tions at high risk for cervical cancer  [1] but not in low-risk 
populations  [10] .
Table 3.  Performance of conventional cytology and LBC in diagnosing CIN1+ and CIN2+
Gold
standard 
(biopsy)
Cyto-
logical
criterion
Type of 
cytology
Sensitivity, % Specificity, % Positive PV, % Negative PV, % AUC p 
value
CIN1+ ASC-H+ conventional 90.9 (86.1 – 94.4) 28.2 (18.1 – 40.1) 78.8 (73.0 – 83.7) 51.3 (34.8 – 67.6) 0.595 (0.535 – 0.653) 0.305
LBC 91.6 (87.4 – 94.8) 19.8 (12.0 – 29.8) 76.0 (70.7 – 80.9) 45.9 (29.5 – 63.1) 0.557 (0.501 – 0.612)
LSIL+ conventional 75.0 (68.5 – 80.7) 62.0 (49.7 – 73.2) 85.2 (79.3 – 90.0) 45.8 (35.6 – 56.3) 0.685 (0.627 – 0.739) 0.254
LBC 75.7 (69.8 – 81.0) 51.2 (40.1 – 62.1) 81.2 (75.4 – 86.1) 43.1 (33.4 – 53.3) 0.634 (0.580 – 0.687)
HSIL+ conventional 53.4 (46.3– 60.3) 80.3 (69.1 – 88.8) 88.8 (81.9 – 93.7) 37.0 (29.4 – 45.2) 0.668 (0.610 – 0.723) 0.309
LBC 51.9 (45.3 – 58.4) 73.3 (62.6 – 82.2) 84.4 (77.5 – 89.8) 35.4 (28.4 – 42.9) 0.626 (0.571 – 0.678)
CIN2+ ASC-H+ conventional 96.0 (91.6 – 98.5) 25.8 (18.5 – 34.3) 60.4 (53.9 – 66.6) 84.6 (69.5 – 94.1) 0.609 (0.549 – 0.667) 0.021
LBC 92.2 (87.4 – 95.6) 16.5 (10.7 – 24.0) 61.5 (55.6 – 67.1) 59.5 (42.1 – 75.2) 0.544 (0.488 – 0.599)
LSIL+ conventional 80.8 (73.6 – 86.7) 52.3 (43.3 – 61.2) 66.7 (59.3 – 73.4) 69.8 (59.6 – 78.7) 0.666 (0.607 – 0.721) 0.049
LBC 76.0 (69.4 – 81.9) 42.1 (33.6 – 51.0) 65.5 (58.8 – 71.7) 54.9 (44.7 – 64.8) 0.591 (0.535 – 0.645)
HSIL+ conventional 64.2 (56.0 – 71.9) 78.1 (70.0 – 84.9) 77.6 (69.3 – 84.6) 64.9 (56.8 – 72.4) 0.712 (0.655 – 0.764) 0.482
LBC 60.4 (53.1 – 67.4) 76.7 (68.6 – 83.6) 78.9 (71.4 – 85.2) 57.3 (49.7 – 64.7) 0.686 (0.632 – 0.736)
 Figures in parentheses represent 95% confidence intervals. PV = Predictive value; ASC-H = atypical squamous cells – cannot exclude 
HSIL.
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 The AUC can be used to evaluate the most accurate 
model for diagnosing CIN; the higher the value of this 
area, the more accurate the model is in predicting CIN. 
To diagnose CIN1+, the largest AUC was found when 
LSIL+ was used as the cytological criterion. In this situa-
tion, both LBC and the conventional preparation had the 
same performance in diagnosing CIN1+. In the same 
manner, diagnosing CIN2+ using HSIL+ as the cytologi-
cal criterion led to the highest AUCs, and both types of 
cytology had similar performances. Although these find-
ings partially support the European meta-analysis  [10] , 
the better performance of LBC to detect HSILs in an as-
sumed ‘population with an increased risk of HPV-in-
duced diseases’ clearly obligated us to be confident with 
LBC and to carefully follow the women with HSILs that 
had not been confirmed by biopsy. The design of the cur-
rent study presumed that in a population at low risk for 
HPV-induced lesions, there would be a lower prevalence 
of squamous intraepithelial lesions with supposed lower 
detection by cytology, which would be expected for post-
HPV vaccination women  [15] ; in contrast, high-risk pop-
ulations should facilitate the identification of squamous 
intraepithelial lesions by cytology. However, with the 
number of cases we evaluated, biopsy confirmation 
should have been much greater to detect statistically rel-
evant differences (data not shown).
 Finally, LBC preparations are generally free of the bi-
ases related to conventional slides because both the sam-
ple preparation and staining procedures are automated. 
Even assuming a scenario in which LBC and convention-
al smears perform similarly, LBC is preferred due to the 
higher quality of the technical preparation and other po-
tential inherent additional actions, including performing 
molecular HPV testing  [16] , creating a biological bank 
using the residual LBC material  [17] and screening the 
results using computer-assisted systems  [18] . The meth-
odological superiority of LBC over conventional smears 
was clearly demonstrated several years ago by Hutchin-
son et al.  [19] , who identified nonhomogeneous cellular 
transfer from the sampling device to the slide as an im-
portant contributing factor that affected the efficacy of 
the conventional Pap smear; these authors observed that 
the abnormal cellularity varied significantly in 4 consecu-
tive smears from the same woman. In contrast, LBC prep-
arations maintained a constant diagnostic cellularity on 
each replicated preparation  [19] . Recently, Kitchener et 
al.  [20] provided robust arguments favoring LBC in the 
ARTISTIC trial, reporting an impressive study in which 
LBC performance was evaluated in detail compared with 
HPV testing. To initiate the trial, 10 laboratory members 
were exhaustively trained to read LBC slides and evaluate 
the time consumed in reading these preparations. This 
step was critical because the cytoscreener had to feel con-
fident about the particular differences between conven-
tional and LBC preparations  [21] . This commentary is 
pertinent because our cytoscreeners and cytopathologists 
are very qualified professionals with a large amount of 
experience in reading conventional smears but not LBC. 
Despite the LBC training prior to the start of the study, 
the differences in familiarity between the 2 methodolo-
gies comprised several years and thousands of slides at the 
time the study started. This could explain, in part, the dif-
ferences in the sensitivity and specificity indices between 
the RODEO and ARTISTIC trials; the former reported a 
sensitivity and specificity of 92.9 and 89.3%, respectively, 
while the latter reported a sensitivity and specificity of 
60.4 and 76.7%, respectively.
 Finally, our perception of LBC and its related facilities 
is that technological improvements in preparing cytolog-
ical samples have contributed significantly to the en-
hancement of the detection of cytological abnormalities.
 Disclosure Statement 
 This study was partially supported by BD, which donated the 
SurePath vials and Papanicolaou staining reagents. The study de-
sign, statistical analyses, interpretation of the results and manu-
script development were carried out by the team of the Barretos 
Cancer Hospital with no involvement from BD.
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